The Grapefruit Interaction, and Why It Appears in Supplements

The grapefruit interaction is well known as a food warning and much less known as a supplement ingredient issue.

The mechanism

Grapefruit contains furanocoumarins, principally bergamottin and related compounds, which irreversibly inhibit intestinal CYP3A4. Because that enzyme performs first-pass metabolism of many oral drugs, inhibiting it means more of the drug reaches circulation — sometimes substantially more. The inhibition is irreversible, so the effect persists until new enzyme is synthesised, which takes a day or more. Separating the timing does not avoid it.

Which drugs are affected

A long list, including certain statins where raised levels increase myopathy risk, some calcium channel blockers, certain immunosuppressants, some antiarrhythmics, some benzodiazepines and others. The magnitude varies by drug. Prescribing information for affected medicines typically carries an explicit grapefruit warning, which is why people who take them are usually told to avoid the fruit and juice.

Why it matters in supplements

Grapefruit extract and grapefruit seed extract appear in some multi-ingredient supplement formulas, marketed for antioxidant or metabolic properties. A person carefully avoiding grapefruit juice because of their statin may take a supplement containing grapefruit extract without any idea it is there. This is a concrete example of why a full ingredient list matters, and why a product with two conflicting published lists is a genuine problem rather than a technicality.

Where a supplement fits here

If you have worked through the medical and behavioural options above and want to add a supplement, Cognicept is a liquid formula available from the Cognicept official website. We would rather you addressed sleep, activity, hearing and any underlying medical cause first — those have far stronger evidence than anything in a bottle, including ours. See our honest assessment for the full picture.